Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,639
Closed -$397K 6
2023
Q2
$397K Sell
3,639
-1,708
-32% -$182K 0.63% 48
2023
Q1
$541K Sell
5,347
-336
-6% -$35.5K 0.66% 31
2022
Q4
$624K Sell
5,683
-5,749
-50% -$595K 0.72% 22
2022
Q3
$1.11M Sell
11,432
-3,816
-25% -$407K 1.26% 3
2022
Q2
$1.66M Buy
15,248
+7,041
+86% +$800K 1.14% 4
2022
Q1
$971K Buy
8,207
+1,725
+27% +$214K 0.73% 17
2021
Q4
$912K Buy
+6,482
New +$830K 0.97% 9

Other funds holding ABT

Delphia (USA)'s ABT Position: Q3 2023 in Review

Delphia (USA) sold out of Abbott (ABT) in Q3 2023, closing a stake of 3,639 shares — an estimated $397K sold.

Delphia (USA) first reported a position in ABT in Q4 2021 and held it in 7 quarters. The position peaked at $1.66M in Q2 2022. 2,682 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

  • Delphia (USA) reported no remaining Abbott position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 3,639 Abbott shares in Q3 2023, an estimated $397K.
  • Delphia (USA) first reported a position in Abbott in Q4 2021 and held it in 7 quarters.
  • Delphia (USA)'s Abbott position peaked at $1.66M in Q2 2022.
  • 2,682 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.